ELEVANCE HEALTH, INC. financials

  1. Home
  2. Company Facts
  3. ELV
ELV CIK 0001156039

Source: EDGAR filings · raw companyfacts JSON · Built 2026-04-25T10:02:01Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 3.17B 4.55B 6.76B 7.25B 7.28B 9.67B
EBITDA 7.29B 7.97B 8.61B 8.41B 7.70B 6.54B
Working Capital 21.97B 18.36B 18.24B 15.92B 16.24B 16.30B
Net Debt 23.21B 23.75B 19.44B 17.66B 21.84B 18.77B
Gross Margin 89.36% 88.84% 89.91% 91.68% 92.14% 92.65%
Operating Margin 3.62% 4.44% 4.96% 5.29% 5.45% 5.22%
Net Margin 2.84% 3.38% 3.49% 3.76% 4.44% 3.75%
Return on Equity (ROE) 12.90% 14.47% 15.23% 16.26% 17.06% 13.77%
Return on Assets (ROA) 4.66% 5.12% 5.50% 5.74% 6.32% 5.28%
Current Ratio 1.5353 1.4525 1.4364 1.4011 1.4654 1.5534
Debt-to-Equity 0.7453 0.7756 0.6607 0.6911 0.7403 0.7384
Effective Tax Rate 15.63% 24.46% 22.35% 22.53% 23.09% 26.71%
Cash Conversion Ratio 0.7577 0.9712 1.3464 1.425 1.3582 2.3377
Accruals Ratio 0.0113 0.0015 -0.019 -0.0244 -0.0226 -0.0706
SBC % of Revenue 0.14% 0.11% 0.17% 0.17% 0.18% 0.23%
CapEx Coverage 3.8441 4.6242 6.2199 7.2908 7.6946 10.4682
Free Cash Flow Per Share $14.13 $19.54 $28.50 $29.85 $29.49 $38.01

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 13.9052 14.3653 18.6979 21.1273 18.5788 17.8582
P/FCF 24.8058 18.8745 16.5482 17.1863 15.721 8.4466
FCF Yield 4.03% 5.30% 6.04% 5.82% 6.36% 11.84%
EV / EBITDA 13.7926 13.5148 15.0302 16.622 17.4025 14.9279
P/S 0.3886 0.4741 0.6415 0.7795 0.8084 0.6466
P/B 1.7632 2.0312 2.7962 3.368 3.1049 2.3734

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 199.13B 177.01B 171.34B 156.59B 138.64B 121.87B
Cost of Goods and Services Sold 21.18B 19.75B 17.29B 13.04B 10.89B 8.95B
Selling, General and Administrative Expense 20.98B 20.02B 20.09B 17.70B 15.92B 17.45B
Operating Income (Loss) 7.20B 7.86B 8.50B 8.28B 7.56B 6.36B
Income Tax Expense (Benefit) 1.05B 1.93B 1.72B 1.71B 1.85B 1.67B
Net Income (Loss) Attributable to Parent 5.66B 5.98B 5.99B 5.89B 6.16B 4.57B
Earnings Per Share, Basic $25.28 $25.81 $25.38 $24.56 $25.26 $18.23
Weighted Average Number of Shares Outstanding, Basic 224.00M 231.70M 235.90M 240.00M 243.80M 250.80M
Earnings Per Share, Diluted $25.21 $25.68 $25.22 $24.28 $24.95 $17.98
Weighted Average Number of Shares Outstanding, Diluted 224.60M 232.90M 237.40M 242.80M 246.80M 254.30M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 9.49B 8.29B 6.53B 7.39B 4.88B 5.74B
Assets, Current 63.00B 58.94B 60.03B 55.62B 51.12B 45.75B
Assets 121.49B 116.89B 108.93B 102.75B 97.46B 86.61B
Long-term Debt 31.90B 30.87B 24.89B 23.85B 22.76B 20.04B
Liabilities, Current 41.03B 40.58B 41.79B 39.70B 34.88B 29.45B
Long-term Debt, Excluding Current Maturities 30.80B 29.22B 23.25B 22.35B 21.16B 19.34B
Liabilities 77.47B 75.46B 69.52B 66.42B 61.29B 53.42B
Stockholders' Equity Attributable to Parent 43.88B 41.31B 39.31B 36.24B 36.09B 33.20B
Common Stock, Shares, Outstanding 220.72M 227.48M 233.07M 237.96M 241.77M 245.40M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 4.29B 5.81B 8.06B 8.40B 8.36B 10.69B
Payments to Acquire Property, Plant, and Equipment 1.12B 1.26B 1.30B 1.15B 1.09B 1.02B
Net Cash Provided by (Used in) Investing Activities -1.34B -5.17B -5.57B -4.56B -9.64B -7.32B
Payments for Repurchase of Common Stock 2.60B 2.90B 2.68B 2.32B 1.90B 2.70B
Payments of Dividends 1.53B 1.51B 1.40B 1.23B 1.10B 954.00M
Net Cash Provided by (Used in) Financing Activities -1.74B 1.19B -3.35B -1.32B 423.00M -2.57B

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Income Statement

23 concepts 3 units
Unit US$ · 17 concepts
Label Value Period
Net Investment Income 765.00M 2026-01-01 → 2026-03-31
Premiums Earned, Net 41.02B 2026-01-01 → 2026-03-31
Revenues 50.18B 2026-01-01 → 2026-03-31
Benefits, Losses and Expenses 47.88B 2026-01-01 → 2026-03-31
Cost of Goods and Services Sold 5.46B 2026-01-01 → 2026-03-31
Policyholder Benefits and Claims Incurred, Net 35.62B 2026-01-01 → 2026-03-31
Amortization of Intangible Assets 112.00M 2026-01-01 → 2026-03-31
Asset Impairment Charges 4.00M 2026-01-01 → 2026-03-31
Selling, General and Administrative Expense 6.33B 2026-01-01 → 2026-03-31
Operating Income (Loss) 2.09B 2026-01-01 → 2026-03-31
InterestExpenseNonoperating 357.00M 2026-01-01 → 2026-03-31
Income (Loss) from Equity Method Investments 305.00M 2026-01-01 → 2026-03-31
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 2.30B 2026-01-01 → 2026-03-31
Income Tax Expense (Benefit) 544.00M 2026-01-01 → 2026-03-31
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 1.76B 2026-01-01 → 2026-03-31
Net Income (Loss) Attributable to Noncontrolling Interest -4.00M 2026-01-01 → 2026-03-31
Net Income (Loss) Attributable to Parent 1.76B 2026-01-01 → 2026-03-31
Unit shares · 3 concepts
Label Value Period
Weighted Average Number of Shares Outstanding, Basic 219.80M 2026-01-01 → 2026-03-31
Weighted Average Number of Shares Outstanding, Diluted 220.40M 2026-01-01 → 2026-03-31
Weighted Average Number Diluted Shares Outstanding Adjustment 600,000 2026-01-01 → 2026-03-31
Unit US$ / share · 3 concepts
Label Value Period
Earnings Per Share, Basic $8.03 2026-01-01 → 2026-03-31
Earnings Per Share, Diluted $8.00 2026-01-01 → 2026-03-31
Common Stock, Dividends, Per Share, Declared $1.72 2026-01-01 → 2026-03-31

Comprehensive Income

10 concepts 1 unit
Unit US$ · 10 concepts
Label Value Period
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax -4.00M 2026-01-01 → 2026-03-31
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax -401.00M 2026-01-01 → 2026-03-31
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax -43.00M 2026-01-01 → 2026-03-31
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax -3.00M 2026-01-01 → 2026-03-31
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax -308.00M 2026-01-01 → 2026-03-31
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax -275.00M 2026-01-01 → 2026-03-31
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.47B 2026-01-01 → 2026-03-31
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 0 2026-01-01 → 2026-03-31
Other Comprehensive Income (Loss), Net of Tax -290.00M 2026-01-01 → 2026-03-31
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax -1.00M 2026-01-01 → 2026-03-31

Balance Sheet

49 concepts 3 units
Unit US$ · 42 concepts
Label Value Period
Cash and Cash Equivalents, at Carrying Value 9.66B as of 2026-03-31
Restricted Cash and Investments, Current 527.00M as of 2026-03-31
Equity Securities, FV-NI 1.51B as of 2026-03-31
Debt Securities, Available-for-sale, Current 25.91B as of 2026-03-31
Debt Securities, Available-for-sale 27.02B as of 2026-03-31
Securities Held as Collateral, at Fair Value 3.00B as of 2026-03-31
Premium Receivable, Allowance for Credit Loss 205.00M as of 2026-03-31
Other Assets, Current 7.17B as of 2026-03-31
Assets, Current 67.03B as of 2026-03-31
Premiums Receivable, Net 11.53B as of 2026-03-31
Accrued Investment Income Receivable 299.00M as of 2026-03-31
Property, Plant and Equipment, Net 4.66B as of 2026-03-31
Liability for Claims and Claims Adjustment Expense 18.43B as of 2026-03-31
Debt Securities, Available-for-sale, Noncurrent 1.11B as of 2026-03-31
Other Policyholder Funds 3.86B as of 2026-03-31
Other Long-term Investments 11.01B as of 2026-03-31
Goodwill 28.34B as of 2026-03-31
Intangible Assets, Net (Excluding Goodwill) 11.09B as of 2026-03-31
Other Assets, Noncurrent 2.58B as of 2026-03-31
Liability for Unpaid Claims and Claims Adjustment Expense, Net 18.07B as of 2026-03-31
Unearned Premiums 1.76B as of 2026-03-31
Assets 125.83B as of 2026-03-31
Accrued Income Taxes, Current 984.00M as of 2026-03-31
Accounts Payable and Accrued Liabilities, Current 6.21B as of 2026-03-31
Long-term Debt 31.12B as of 2026-03-31
Short-term Debt 724.00M as of 2026-03-31
Long-term Debt, Current Maturities 350.00M as of 2026-03-31
Other Liabilities, Current 13.98B as of 2026-03-31
Liabilities, Current 45.31B as of 2026-03-31
Long-term Debt, Excluding Current Maturities 30.77B as of 2026-03-31
Deferred Income Tax Liabilities, Net 1.79B as of 2026-03-31
Other Liabilities, Noncurrent 3.92B as of 2026-03-31
Liabilities 81.78B as of 2026-03-31
Preferred Stock, Value, Issued 0 as of 2026-03-31
Common Stock, Value, Issued 2.00M as of 2026-03-31
Additional Paid in Capital 8.85B as of 2026-03-31
Accumulated Other Comprehensive Income (Loss), Net of Tax -741.00M as of 2026-03-31
Retained Earnings (Accumulated Deficit) 35.80B as of 2026-03-31
Stockholders' Equity Attributable to Parent 43.90B as of 2026-03-31
Stockholders' Equity Attributable to Noncontrolling Interest 140.00M as of 2026-03-31
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 44.04B as of 2026-03-31
Liabilities and Equity 125.83B as of 2026-03-31
Unit shares · 6 concepts
Label Value Period
Preferred Stock, Shares Authorized 100.00M as of 2026-03-31
Preferred Stock, Shares Issued 0 as of 2026-03-31
Preferred Stock, Shares Outstanding 0 as of 2026-03-31
Common Stock, Shares Authorized 900.00M as of 2026-03-31
Common Stock, Shares, Issued 217.37M as of 2026-03-31
Common Stock, Shares, Outstanding 217.37M as of 2026-03-31
Unit US$ / share · 1 concept
Label Value Period
Common Stock, Par or Stated Value Per Share $0.01 as of 2026-03-31

Cash Flow Statement

34 concepts 1 unit
Unit US$ · 34 concepts
Label Value Period
Depreciation, Amortization and Accretion, Net 354.00M 2026-01-01 → 2026-03-31
Increase (Decrease) in Accounts Payable and Other Operating Liabilities 2.89B 2026-01-01 → 2026-03-31
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid 33.26B 2026-01-01 → 2026-03-31
Share-based Payment Arrangement, Noncash Expense 55.00M 2026-01-01 → 2026-03-31
Deferred Income Tax Expense (Benefit) -274.00M 2026-01-01 → 2026-03-31
Increase (Decrease) in Receivables 1.17B 2026-01-01 → 2026-03-31
Increase (Decrease) in Debt Securities, Trading, and Equity Securities, FV-NI 0 2026-01-01 → 2026-03-31
Increase (Decrease) in Insurance Liabilities 1.59B 2026-01-01 → 2026-03-31
Increase (Decrease) in Other Operating Assets 1.55B 2026-01-01 → 2026-03-31
Increase (Decrease) in Deferred Revenue 266.00M 2026-01-01 → 2026-03-31
Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable 644.00M 2026-01-01 → 2026-03-31
Net Cash Provided by (Used in) Operating Activities 4.33B 2026-01-01 → 2026-03-31
Payments to Acquire Property, Plant, and Equipment 235.00M 2026-01-01 → 2026-03-31
Payments to Acquire Investments 4.74B 2026-01-01 → 2026-03-31
Proceeds from Sale of Debt Securities, Available-for-sale 2.94B 2026-01-01 → 2026-03-31
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 552.00M 2026-01-01 → 2026-03-31
Increase (Decrease) in Collateral Held under Securities Lending 313.00M 2026-01-01 → 2026-03-31
Payments to Acquire Businesses, Net of Cash Acquired -5.00M 2026-01-01 → 2026-03-31
Payments for (Proceeds from) Other Investing Activities 10.00M 2026-01-01 → 2026-03-31
Net Cash Provided by (Used in) Investing Activities -1.64B 2026-01-01 → 2026-03-31
Increase (Decrease) in Outstanding Checks, Financing Activities -1.15B 2026-01-01 → 2026-03-31
Proceeds from Short-term Debt 724.00M 2026-01-01 → 2026-03-31
Repayments of Short-term Debt 150.00M 2026-01-01 → 2026-03-31
Repayments of Long-term Debt 750.00M 2026-01-01 → 2026-03-31
Increase (Decrease) in Securities Lending Payable 313.00M 2026-01-01 → 2026-03-31
Proceeds from Stock Options Exercised 37.00M 2026-01-01 → 2026-03-31
Payments for Repurchase of Common Stock 1.12B 2026-01-01 → 2026-03-31
Payments of Dividends 376.00M 2026-01-01 → 2026-03-31
Payment, Tax Withholding, Share-based Payment Arrangement 34.00M 2026-01-01 → 2026-03-31
Proceeds from (Payments for) Other Financing Activities -3.00M 2026-01-01 → 2026-03-31
Net Cash Provided by (Used in) Financing Activities -2.52B 2026-01-01 → 2026-03-31
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents -9.00M 2026-01-01 → 2026-03-31
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 166.00M 2026-01-01 → 2026-03-31
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.66B as of 2026-03-31

Notes

77 concepts 7 units
Unit US$ · 50 concepts
Label Value Period
Malpractice Loss Contingency, Letters of Credit and Surety Bonds 781.00M as of 2026-03-31
Cash and Cash Equivalents, Fair Value Disclosure 5.74B as of 2026-03-31
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Operating Expense 1.06B 2026-01-01 → 2026-03-31
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement 44.00M as of 2026-03-31
Financial Liabilities Fair Value Disclosure 53.00M as of 2026-03-31
Derivative, Gain on Derivative 1.00M 2026-01-01 → 2026-03-31
Dividends, Common Stock 378.00M 2026-01-01 → 2026-03-31
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One 203.00M as of 2026-03-31
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five 3.86B as of 2026-03-31
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 9.35B as of 2026-03-31
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10 5.55B as of 2026-03-31
Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost 8.33B as of 2026-03-31
Business Combination, Liabilities Arising from Contingencies, Amount Recognized 1.33B as of 2026-03-31
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One 200.00M as of 2026-03-31
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five 3.85B as of 2026-03-31
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 9.40B as of 2026-03-31
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement 53.00M as of 2026-03-31
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 5.47B as of 2026-03-31
Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value 8.10B as of 2026-03-31
Stock Repurchase Program, Remaining Authorized Repurchase Amount 5.57B as of 2026-03-31
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments 45.00M as of 2026-03-31
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss 170.00M as of 2026-03-31
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss 441.00M as of 2026-03-31
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax 387.00M as of 2026-03-31
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax 611.00M as of 2026-03-31
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months 9.04B as of 2026-03-31
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer 3.66B as of 2026-03-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value 33.00M as of 2026-03-31
Securities Loaned, Fair Value of Collateral 3.00B as of 2026-03-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value 33.00M as of 2026-03-31
Derivative Liability, Collateral, Right to Reclaim Cash, Offset 9.00M as of 2026-03-31
Assets, Fair Value Disclosure 37.32B as of 2026-03-31
Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions 0 2026-01-01 → 2026-03-31
Current Year Claims and Claims Adjustment Expense 35.68B 2026-01-01 → 2026-03-31
Prior Year Claims and Claims Adjustment Expense -1.12B 2026-01-01 → 2026-03-31
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims 34.55B 2026-01-01 → 2026-03-31
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year 23.01B 2026-01-01 → 2026-03-31
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years 10.25B 2026-01-01 → 2026-03-31
Debt Securities, Available-for-sale, Allowance for Credit Loss 55.00M as of 2026-03-31
Other Comprehensive Income (Loss) before Reclassifications, Tax -93.00M 2026-01-01 → 2026-03-31
Reclassification from AOCI, Current Period, Tax -10.00M 2026-01-01 → 2026-03-31
Other Comprehensive Income, Other, Net of Tax -18.00M 2026-01-01 → 2026-03-31
Income Taxes Receivable, Current 776.00M as of 2026-03-31
Other Receivables 6.17B as of 2026-03-31
Allowance for Doubtful Other Receivables, Current 1.62B as of 2026-03-31
Debt Securities, Available-for-sale, Allowance for Credit Loss, Current 55.00M as of 2026-03-31
Debt Securities, Available-for-sale, Allowance for Credit Loss, Noncurrent 0 as of 2026-03-31
Debt Securities, Available-for-sale, Amortized Cost, Current 26.18B as of 2026-03-31
Debt Securities, Available-for-sale, Amortized Cost, Noncurrent 1.12B as of 2026-03-31
Debt Securities, Available-for-sale, Amortized Cost 27.30B as of 2026-03-31
Unit shares · 8 concepts
Label Value Period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 3.80M as of 2026-03-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 100,000 2026-01-01 → 2026-03-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 100,000 2026-01-01 → 2026-03-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 2.40M as of 2026-03-31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.60M as of 2026-03-31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 900,000 2026-01-01 → 2026-03-31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 300,000 2026-01-01 → 2026-03-31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 100,000 2026-01-01 → 2026-03-31
Unit US$ / share · 11 concepts
Label Value Period
Treasury Stock Acquired, Average Cost Per Share $304.68 2026-01-01 → 2026-03-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $359.64 as of 2026-03-31
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $294.07 2026-01-01 → 2026-03-31
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price $177.10 2026-01-01 → 2026-03-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price $408.64 2026-01-01 → 2026-03-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value $75.79 2026-01-01 → 2026-03-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $369.90 as of 2026-03-31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $355.27 as of 2026-03-31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $294.27 2026-01-01 → 2026-03-31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value $454.19 2026-01-01 → 2026-03-31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value $453.74 2026-01-01 → 2026-03-31
Unit pure · 4 concepts
Label Value Period
Effective Income Tax Rate Reconciliation, Percent 0.236 2026-01-01 → 2026-03-31
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 0.31 2026-01-01 → 2026-03-31
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 0.0397 2026-01-01 → 2026-03-31
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 0.0059 2026-01-01 → 2026-03-31
Unit security · 2 concepts
Label Value Period
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions 2,642 as of 2026-03-31
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions 2,662 as of 2026-03-31
Unit segment · 1 concept
Label Value Period
Number of Reportable Segments 4 2026-01-01 → 2026-03-31
Unit state · 1 concept
Label Value Period
Number of States in which Entity Operates 50 as of 2026-03-31

Other

4 concepts 2 units
Unit US$ · 2 concepts
Label Value Period
Stock Issued During Period, Value, Stock Options Exercised 58.00M 2026-01-01 → 2026-03-31
Stock Repurchased and Retired During Period, Value 1.12B 2026-01-01 → 2026-03-31
Unit shares · 2 concepts
Label Value Period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 900,000 2026-01-01 → 2026-03-31
Stock Repurchased and Retired During Period, Shares 3.70M 2026-01-01 → 2026-03-31

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (ELV CIK 0001156039), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.